相似文献
1
Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR.
J Clin Microbiol. 1998 Sep;36(9):2748-51. doi: 10.1128/JCM.36.9.2748-2751.1998.
2
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.
J Clin Microbiol. 1999 Jul;37(7):2158-64. doi: 10.1128/JCM.37.7.2158-2164.1999.
3
Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.
J Clin Pathol. 1999 Mar;52(3):173-6. doi: 10.1136/jcp.52.3.173.
4
Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei.
J Clin Microbiol. 1998 Sep;36(9):2737-41. doi: 10.1128/JCM.36.9.2737-2741.1998.
5
Species-specific PCR as a tool for the identification of Burkholderia gladioli.
J Clin Microbiol. 2000 Jan;38(1):282-5. doi: 10.1128/JCM.38.1.282-285.2000.
6
Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR.
J Clin Microbiol. 1999 May;37(5):1335-9. doi: 10.1128/JCM.37.5.1335-1339.1999.
7
Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.
J Clin Microbiol. 1999 Jul;37(7):2201-8. doi: 10.1128/JCM.37.7.2201-2208.1999.
8
Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.
J Clin Microbiol. 1999 Oct;37(10):3167-70. doi: 10.1128/JCM.37.10.3167-3170.1999.
9
Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneity.
APMIS. 2001 May;109(5):389-400. doi: 10.1034/j.1600-0463.2001.090508.x.
10
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
J Clin Microbiol. 2001 Mar;39(3):1073-8. doi: 10.1128/JCM.39.3.1073-1078.2001.
引用本文的文献
1
Unique Presentations of Infections in Several Strains of Immunocompromised Mice.
Comp Med. 2023 Oct 29;73(5):391-397. doi: 10.30802/AALAS-CM-23-000016. Epub 2023 Sep 20.
2
Research on the establishment and application of protein fingerprint spectrum database of in Hainan Province China.
New Microbes New Infect. 2021 Sep 1;43:100938. doi: 10.1016/j.nmni.2021.100938. eCollection 2021 Sep.
3
Discrimination of pv. and complex using the B gene of .
Exp Ther Med. 2019 Mar;17(3):1870-1876. doi: 10.3892/etm.2018.7137. Epub 2018 Dec 28.
4
Laboratory diagnosis of melioidosis: past, present and future.
Exp Biol Med (Maywood). 2015 Jun;240(6):742-51. doi: 10.1177/1535370215583801. Epub 2015 Apr 22.
5
Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.
J Clin Microbiol. 2009 May;47(5):1510-6. doi: 10.1128/JCM.02489-08. Epub 2009 Mar 18.
6
Two cases of keratitis and corneal ulcers caused by Burkholderia gladioli.
J Clin Microbiol. 2008 Jul;46(7):2445-9. doi: 10.1128/JCM.02442-07. Epub 2008 Apr 23.
7
Invasion of spores of the arbuscular mycorrhizal fungus Gigaspora decipiens by Burkholderia spp.
Appl Environ Microbiol. 2003 Oct;69(10):6250-6. doi: 10.1128/AEM.69.10.6250-6256.2003.
8
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study.
J Clin Microbiol. 2003 Sep;41(9):4113-20. doi: 10.1128/JCM.41.9.4113-4120.2003.
9
Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.
J Clin Microbiol. 2002 Oct;40(10):3793-7. doi: 10.1128/JCM.40.10.3793-3797.2002.
10
Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.
J Clin Microbiol. 2002 May;40(5):1743-8. doi: 10.1128/JCM.40.5.1743-1748.2002.
本文引用的文献
1
A BACTERIAL DISEASE OF GLADIOLUS.
Science. 1921 Aug 5;54(1388):115-6. doi: 10.1126/science.54.1388.115.
2
Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei.
J Clin Microbiol. 1998 Sep;36(9):2737-41. doi: 10.1128/JCM.36.9.2737-2741.1998.
3
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
Int J Syst Bacteriol. 1997 Oct;47(4):1188-200. doi: 10.1099/00207713-47-4-1188.
4
Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis.
Am J Respir Crit Care Med. 1997 Apr;155(4):1436-40. doi: 10.1164/ajrccm.155.4.9105090.
5
Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli.
J Antimicrob Chemother. 1997 Feb;39(2):169-75. doi: 10.1093/jac/39.2.169.
6
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
J Clin Microbiol. 1997 Mar;35(3):614-9. doi: 10.1128/jcm.35.3.614-619.1997.
7
Succession and convergence of biofilm communities in fixed-film reactors treating aromatic hydrocarbons in groundwater.
Appl Environ Microbiol. 1997 Jan;63(1):270-6. doi: 10.1128/aem.63.1.270-276.1997.
8
Chronic granulomatous disease presenting as severe sepsis due to Burkholderia gladioli.
Clin Infect Dis. 1996 Aug;23(2):411. doi: 10.1093/clinids/23.2.411.
9
Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation.
Pediatr Infect Dis J. 1996 Jul;15(7):637-9. doi: 10.1097/00006454-199607000-00020.
10
Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases.
Clin Infect Dis. 1995 Nov;21(5):1291-3. doi: 10.1093/clinids/21.5.1291.
Zotero 插件